WO2007009638A3 - Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung - Google Patents

Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung Download PDF

Info

Publication number
WO2007009638A3
WO2007009638A3 PCT/EP2006/006777 EP2006006777W WO2007009638A3 WO 2007009638 A3 WO2007009638 A3 WO 2007009638A3 EP 2006006777 W EP2006006777 W EP 2006006777W WO 2007009638 A3 WO2007009638 A3 WO 2007009638A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
complexes containing
containing perfluoroalkyl
field
perfluoroalky
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/006777
Other languages
English (en)
French (fr)
Other versions
WO2007009638A2 (de
Inventor
Heiko Schirmer
Hanns-Joachim Weinmann
Johannes Platzek
Ludwig Zorn
Bernd Misselwitz
Joerg Meding
Heribert Schmitt-Willich
Thomas Brumby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Epix Pharmaceuticals Inc
Original Assignee
Schering AG
Epix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG, Epix Pharmaceuticals Inc filed Critical Schering AG
Priority to BRPI0613407-6A priority Critical patent/BRPI0613407A2/pt
Priority to EP06791535A priority patent/EP1904463A2/de
Priority to JP2008520780A priority patent/JP2009501174A/ja
Priority to CA002615443A priority patent/CA2615443A1/en
Priority to AU2006272025A priority patent/AU2006272025A1/en
Publication of WO2007009638A2 publication Critical patent/WO2007009638A2/de
Publication of WO2007009638A3 publication Critical patent/WO2007009638A3/de
Priority to IL187926A priority patent/IL187926A0/en
Priority to TNP2008000016A priority patent/TNSN08016A1/en
Anticipated expiration legal-status Critical
Priority to NO20080813A priority patent/NO20080813L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Die Erfindung betrifft die in den Patentansprüchen gekennzeichneten Gegenstände, nämlich perfluoralkylhaltige Metallkomplexe mit stickstoffhaltigen Resten der allgemeinen Formel I, Verfahren zu deren Herstellung und ihre Verwendung in der NMR- und Röntgendiagnostik, Radiodiagnostik und Radiotherapie, sowie in der MRT-Lymphographie und zum blood pool imaging.
PCT/EP2006/006777 2005-07-15 2006-07-11 Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung Ceased WO2007009638A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
BRPI0613407-6A BRPI0613407A2 (pt) 2005-07-15 2006-07-11 Complexos contendo perfluoralquila, bem como composição farmacêutica, uso e processos de preparação dos mesmos
EP06791535A EP1904463A2 (de) 2005-07-15 2006-07-11 Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung
JP2008520780A JP2009501174A (ja) 2005-07-15 2006-07-11 ペルフルオロアルキル含有錯体、製造方法およびその使用
CA002615443A CA2615443A1 (en) 2005-07-15 2006-07-11 Perfluoroalkyl-containing complexes, process for their production as well as their use
AU2006272025A AU2006272025A1 (en) 2005-07-15 2006-07-11 Complexes containing perfluoroalkyl, method for the production and use thereof
IL187926A IL187926A0 (en) 2005-07-15 2007-12-06 Complexes containing perfluoroalkyl, method for the production and use thereof
TNP2008000016A TNSN08016A1 (en) 2005-07-15 2008-01-14 Complexes containing perfluoroalkyl, method for the production and use thereof
NO20080813A NO20080813L (no) 2005-07-15 2008-02-14 Komplekser inneholdende perfluoralkyl, fremgangsmate for fremstilling og anvendelse derav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033902A DE102005033902B3 (de) 2005-07-15 2005-07-15 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102005033902.6 2005-07-15

Publications (2)

Publication Number Publication Date
WO2007009638A2 WO2007009638A2 (de) 2007-01-25
WO2007009638A3 true WO2007009638A3 (de) 2007-04-26

Family

ID=37057146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/006777 Ceased WO2007009638A2 (de) 2005-07-15 2006-07-11 Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung

Country Status (22)

Country Link
EP (1) EP1904463A2 (de)
JP (1) JP2009501174A (de)
KR (1) KR20080043762A (de)
CN (1) CN101223148A (de)
AR (1) AR054865A1 (de)
AU (1) AU2006272025A1 (de)
BR (1) BRPI0613407A2 (de)
CA (1) CA2615443A1 (de)
CR (1) CR9645A (de)
DE (1) DE102005033902B3 (de)
DO (1) DOP2006000167A (de)
EC (1) ECSP088100A (de)
GT (1) GT200600313A (de)
IL (1) IL187926A0 (de)
NO (1) NO20080813L (de)
PE (1) PE20070376A1 (de)
RU (1) RU2008105356A (de)
TN (1) TNSN08016A1 (de)
TW (1) TW200706538A (de)
UY (1) UY29664A1 (de)
WO (1) WO2007009638A2 (de)
ZA (1) ZA200801523B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
US8361438B2 (en) 2008-01-08 2013-01-29 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
EP4037691A4 (de) * 2019-10-04 2023-11-22 United States Government as Represented by The Department of Veterans Affairs Entwicklung von bildgebenden und therapeutischen glukoseanaloga für natrium-abhängige glukosetransporter
EP4059925A1 (de) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft Neues kontrastmittel zur verwendung in der magnetresonanzbildgebung
CN114181164A (zh) * 2021-12-13 2022-03-15 武汉大学中南医院 基于Fe(Ⅱ)特异性MRI对比剂的合成方法及其应用
EP4335840A1 (de) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft Neue kontrastmittel zur verwendung in der diagnostischen bildgebung
EP4335462A1 (de) 2022-09-09 2024-03-13 Bayer AG Kontrastmittel zur verwendung in der diagnostischen bildgebung mittels computertomografie

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
WO2002013875A2 (de) * 2000-08-11 2002-02-21 Schering Aktiengesellschaft Perfluoralkylhaltige komplexe mit polaren resten, verfahren zu deren herstellung und ihre verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
WO2002013875A2 (de) * 2000-08-11 2002-02-21 Schering Aktiengesellschaft Perfluoralkylhaltige komplexe mit polaren resten, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
JP2009501174A (ja) 2009-01-15
AU2006272025A1 (en) 2007-01-25
DOP2006000167A (es) 2007-02-28
EP1904463A2 (de) 2008-04-02
NO20080813L (no) 2008-04-09
CR9645A (es) 2008-05-21
TNSN08016A1 (en) 2009-07-14
KR20080043762A (ko) 2008-05-19
PE20070376A1 (es) 2007-04-20
RU2008105356A (ru) 2009-08-20
UY29664A1 (es) 2007-02-28
IL187926A0 (en) 2008-03-20
TW200706538A (en) 2007-02-16
WO2007009638A2 (de) 2007-01-25
BRPI0613407A2 (pt) 2011-01-11
CN101223148A (zh) 2008-07-16
CA2615443A1 (en) 2007-01-25
ZA200801523B (en) 2008-11-26
AR054865A1 (es) 2007-07-25
GT200600313A (es) 2007-04-23
ECSP088100A (es) 2008-05-30
DE102005033902B3 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
TNSN08016A1 (en) Complexes containing perfluoroalkyl, method for the production and use thereof
WO2007002109A3 (en) Multidentate pyrone-derived chelators for medicinal imaging and chelation
EP1686891A4 (de) Verwendung von thoraxgeschwindigkeit zur bearbeitung von physiologischen signalen zur entfernung von thoraxkompressionsartefakten
WO2017019184A3 (en) Method and apparatus for removing motion artifacts from biomedical signals
IL202487A (en) Annals of 5,5 '- (hydroxyalkyl-diethyl) bis (formylazandyl) bis (2,4,6-triiodophenyl preserved), a diagnostic factor containing them and methods of diagnosis and imaging containing these factors
GB2428296B (en) Enhancing the acqisition and processing of low frequencies for sub-salt imaging
BRPI0617151B8 (pt) composto, multímero, composto vetorizado, complexo do referido composto, bem como composições farmacêutica, farmacêutica lipídica e de diagnóstico para imagiologia por ressonância magnética e processo para a preparação de um complexo metálico
IS2127B (is) Málmsamstæður sem innihalda Perflúoróalkýl og notkun þeirra við segulsneiðmyndunar-greiningar
IL180896A0 (en) Method of tumour imaging
WO2008082657A3 (en) Mri imageable liposomes for the evaluation of treatment efficacy, thermal distribution. and demonstration of dose painting
WO2007009637A3 (de) Deren verwendung als kontrastmittel zur anwendung in der nmr-, rontgen- und radiodiagnostik sowie in der radiotheraphie
WO2004112839A3 (en) Specific high-relaxivity conjugate compounds for magnetic resonance imaging
ATE361299T1 (de) Oligomere der gadolinium chelate, ihre verwendung als nmr-kontrastmittel und zwischenverbindungen
IL198995A0 (en) Novel compound having affinity for amyloid
EP2022792A8 (de) Neue verbindung mit affinität zu amyloid
DE602006008135D1 (de) Metallchelate von makrocyclischen polyaminocarbonsäurederivaten und deren anwendung bei der diagnostischen bilderzeugung
MY148553A (en) Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use
WO2008134289A3 (en) High relaxivity coordinatively unsaturated lanthanide complexes
WO2004081574A3 (en) Detection, monitoring and treatment of cancer
PL374027A1 (pl) Zastosowanie zawierających grupy perfluoroalkilowe kompleksów metali jako środków kontrastowych w obrazowaniu metodą rezonansu magnetycznego wewnątrznaczyniowych skrzeplin
EP4512815A3 (de) Manganchelatisomere
WO2017066070A3 (en) Acetate complexes and methods for acetate quantification
WO2008025941A3 (en) Compounds for imaging and therapy
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2010135493A3 (en) Alzheimer's disease imaging agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006791535

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 187926

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 9453/DELNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: DZP2007000804

Country of ref document: DZ

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/000352

Country of ref document: MX

Ref document number: CR2008-009645

Country of ref document: CR

WWE Wipo information: entry into national phase

Ref document number: 564967

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2008010068

Country of ref document: EG

Ref document number: 12008500102

Country of ref document: PH

Ref document number: 08002702

Country of ref document: CO

Ref document number: 1020087001084

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200680025890.5

Country of ref document: CN

Ref document number: 2615443

Country of ref document: CA

Ref document number: 2008520780

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2008105356

Country of ref document: RU

Ref document number: 2006272025

Country of ref document: AU

Ref document number: A20080163

Country of ref document: BY

ENP Entry into the national phase

Ref document number: 2006272025

Country of ref document: AU

Date of ref document: 20060711

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006272025

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2006791535

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0613407

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080115